CompletedNot Applicable

Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

38 participantsStarted 2016-10-01

Plain-language summary

The results of the study suggest that an early change in CgA levels might serve as a prognostic factor in NET patients treated with PRRT.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * confirmed NET * peptide receptor radionuclide therapy (PRRT) Exclusion Criteria: * lack of patient consent to a clinical trial

The CgA level change

Timeframe: 2016-2023

NCT IDNCT06183047

SponsorMilitary Institute od Medicine National Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-30